Fractional CTO for Series A BioTech & Life Sciences Startups
Navigate the unique challenges of building a BioTech & Life Sciences company at Series A. Expert technical leadership that understands both scaling engineering and BioTech & Life Sciences-specific requirements.
Typical Funding
$2M - $15M
Team Size
15-40 people
Revenue
$1M - $5M ARR
Runway
24-36 months
What BioTech & Life Sciences Companies Need at Series A
Technical Priorities
- Scale BioTech & Life Sciences infrastructure for 10x growth
- Achieve full GDPR certification
- Build engineering team with BioTech & Life Sciences domain expertise
- Implement advanced BioTech & Life Sciences features for competitive advantage
- Establish security and reliability standards for enterprise customers
Industry-Specific Focus
- Lab information systems
- Data analysis
- Compliance
- Research platforms
- Clinical trials
Why BioTech & Life Sciences at Series A is Different
BioTech & Life Sciences companies at Series A face a unique combination of challenges. While Series A companies focus on scaling engineering, BioTech & Life Sciences adds complexity through GDPR requirements, Lab information systems technical needs, and industry-specific competitive dynamics. Our fractional CTOs understand both dimensions and help you navigate this intersection efficiently.
Challenges We Solve for Series A BioTech & Life Sciences Companies
Series A Challenge
Scaling engineering team 3-5x while maintaining velocity and culture
Series A Challenge
Technical debt from MVP/seed stage becoming major obstacle to development
BioTech & Life Sciences Challenge
Lab information systems at Series A scale
BioTech & Life Sciences Challenge
Data analysis at Series A scale
Technical Leadership Gap
Finding CTO-level expertise who understands both Series A dynamics and BioTech & Life Sciences regulations/requirements
Resource Constraints
Balancing BioTech & Life Sciences compliance requirements with Series A budget and timeline constraints
BioTech & Life Sciences Compliance at Series A
Series A BioTech & Life Sciences companies typically need formal compliance certification to close enterprise deals and satisfy investor due diligence. We guide you through the certification process while building scalable compliance infrastructure.
Stage-Specific Compliance Priority
Achieve GDPR certification within 6-12 months. This is typically required for enterprise sales and next funding round.
BioTech & Life Sciences Benchmarks for Series A
Tech Budget
$280K-$650K/month
Typical monthly tech spend at Series A
Team Size
15-40 people
Engineering team size for Series A
Time to Market
6-12 months
Typical development cycle at Series A
What Investors Expect from Series A BioTech & Life Sciences Companies
Technical Requirements
- BioTech & Life Sciences-appropriate architecture and security measures
- Compliance roadmap for GDPR
- Scalable tech stack proven in BioTech & Life Sciences companies
- Clear technical roadmap aligned with Series A milestones
- Strong engineering team or hiring plan
Key Metrics
- Product velocity: Consistent feature releases
- BioTech & Life Sciences user engagement and retention metrics
- System reliability: 99%+ uptime for production systems
- Security posture: Zero critical vulnerabilities
- Technical efficiency: Cost per user or transaction
Our Approach for Series A BioTech & Life Sciences Startups
Stage Expertise
Deep understanding of Series A dynamics: Scaling Engineering, Enterprise Readiness.
Industry Knowledge
Proven experience with BioTech & Life Sciences compliance, tech stacks, and best practices.
Network Access
Connect with vetted BioTech & Life Sciences engineers, advisors, and technical partners.
Success Story
Series A enterprise SaaS, 25 people, $12M raised, $2.5M ARR, targeting $10M ARR in 18 months
Challenge
Engineering team of 12 couldn't keep up with sales demands. VP Engineering hired 6 months prior was struggling (first VP role). Monolithic Rails app had performance issues and took 2 weeks to deploy simple changes. Multiple enterprise deals blocked on SOC 2. Engineering morale low due to constant firefighting. Board concerned about ability to scale.
Solution
Fractional CTO engaged as advisor to VP Engineering and exec team. First 60 days: conducted engineering assessment, identified critical bottlenecks, defined 12-month transformation roadmap. Key initiatives: 1) Restructured teams into product squads with clear ownership, 2) Hired 2 engineering managers and staff engineer, 3) Initiated microservices migration for core bottlenecks, 4) Implemented proper CI/CD reducing deploy time from 2 weeks to 2 hours, 5) Led SOC 2 Type 2 certification (6 months), 6) Established engineering metrics and OKR process, 7) Coached VP Engineering on leadership and communication, 8) Scaled team from 12 to 35 engineers with quality bar.
Result
Grew from $2.5M to $11M ARR in 18 months with engineering team of 35. Deployment frequency increased from bi-weekly to daily. SOC 2 Type 2 achieved, unblocking $3M in enterprise deals. Engineering engagement scores improved from 6.2 to 8.1. Successfully raised $35M Series B with clean technical diligence. VP Engineering promoted to CTO with confidence. Platform now supports $50M ARR without major rewrites.
Ready to Scale Your Series A BioTech & Life Sciences Startup?
Get expert fractional CTO guidance tailored for your stage and industry. Start with a free assessment.